HomeWidexWidex introduces My Sound: A New Portfolio of AI-enabled Features for Customization of Its Industry-leading Widex MOMENT™ Hearing Aids

Widex introduces My Sound: A New Portfolio of AI-enabled Features for Customization of Its Industry-leading Widex MOMENT™ Hearing Aids

Widex reports: Building on the success of the revolutionary, artificial intelligence-based SoundSense Learn technology, the company announced Widex My Sound, a portfolio of AI features including a new solution that instantly enables intelligent customization of the company’s cutting-edge Widex MOMENT hearing aids based on a users’ activity and listening intent.

Widex introduces My Sound: A new portfolio of AI-enabled features for customization of its industry-leading Widex MOMENT™ hearing aidsWidex was the first company to enable user-driven sound personalization by leveraging artificial intelligence in hearing aids. Now, within My Sound, Widex launches the third generation of its AI technology, vastly improving the usability of the AI solution based on the extensive data the company has gathered from the previous two generations.

This new AI solution further combines the capacity of artificial intelligence with users’ personal real-world experience to deliver another level of automated customization. Through AI modeling and clustering of data collected via the Widex SoundSense Learn AI engine, highly qualified sound profile recommendations for the individual user can now be made based on the intent, need, and preferences of thousands of users in similar real-world situations.

“Widex is leading the industry by combining artificial intelligence and human intelligence to create natural sound experiences and foster social participation through better hearing,” said Jodi Sasaki-Miraglia, AuD, Widex’s Director of Professional Training and Education. “Once Widex Moment is fit properly by a local licensed hearing care professional, the user can, if necessary, customize their hearing aids with ease, choosing from multiple AI features. Plus, our latest generation delivers results in just seconds, putting control and intelligent personalization into the hands of every user.”

WIDEX, Graphical user interface, application Description automatically generated
Graphical user interface, application Description automatically generated

My Sound is integrated into the Widex MOMENT app and is the home for all the powerful AI personalization Widex offers. The latest generation of AI utilizes the cloud-based user data of Widex users worldwide to make sound profile recommendations based on an individual user’s current activity and listening intent. Users launch My Sound from the app and begin by selecting their activity, such as dining, then choosing their intent, such as socializing, conversation, or enjoying music.

Based on the user’s selections, Widex can draw on tens of thousands of real-life data points, reflecting the preferences and listening situations of other Widex users who have used the app previously. In seconds, the user is presented with two recommendations, which can both be listened to before selecting the settings that sound best. In the event neither recommendation meets the individual user’s needs, they can launch SoundSense Learn from the same screen to further personalize their hearing experience through that solution’s sophisticated A/B testing process.

Widex has created a radically different way of delivering hearing solutions for today’s active hearing aid user,” Sasaki-Miraglia continued. “Instead of having to program the hearing aid in a way that covers all situations the user might encounter, the hearing care professional ensures the best possible starting point for the user and My Sound then allows users to personalize their experience in real life, easily and instantly. In this way, the hearing solution adapts to the user’s preferences and becomes even more personal.”

The Widex MOMENT app, including My Sound with SoundSense Learn, is available for Apple and Android devices and is designed to work with Widex MOMENT Bluetooth hearing aids.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy